High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study

Vincenzo Serretta, Michele Battaglia, Paolo Verze, Estevao Lima, Riccardo Autorino, Matteo Ferro, Riccardo Schiavina, Gennaro Musi, Gilberto L. Almeida, Marco Borghesi, Gian Maria Busetto, Mihai Dorin Vartolomei, Nicolae Crisan, Ettore De Berardinis, Rodolfo Hurle, Giorgio Ivan Russo, Giovanni Grimaldi, Abdal Rahman Abu Farhan, Marco Borghesi, Francesco CantielloSisto Perdonà, Ottavio De Cobelli, Pierluigi Bove, Shahrokh F. Shariat, Savino M. Di Stasi, Giuseppe Morgia, Vincenzo Mirone, Giorgio Guazzoni, Rocco Damiano, Michele Battaglia, Giuseppe Lucarelli, Paolo Verze

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

Introduction: The aim of this multicenter study was to investigate the prognostic impact of residual T1 high-grade (HG)/G3 tumors at re-transurethral resection (TUR of bladder tumor) in a large multi-institutional cohort of patients with primary T1 HG/G3 bladder cancer (BC). Patients and Methods: The study period was from January 2002 to December 2012. A total of 1,046 patients with primary T1 HG/G3 and who had non-muscle invasive BC (NMIBC) on reTUR followed by adjuvant intravesical Bacillus Calmette-Guerin (BCG) therapy with maintenance were included. Endpoints were time to disease recurrence, progression, and overall and cancer-specific death. Results: A total of 257 (24.6%) patients had residual T1 HG/G3 tumors. The presence of concomitant carcinoma in situ, multiple and large tumors (> 3 cm) at first TUR were associated with residual T1 HG/G3. Five-year recurrence-free survival (RFS), progression-free survival (PFS), overall survival (OS), and cancerspecific survival (CSS) were 17% (CI 11.8-23); 58.2% (CI 50.765); 73.7% (CI 66.3-79.7); and 84.5% (CI 77.8-89.3), respectively, in patients with residual T1 HG/G3, compared to 36.7% (CI 32.8-40.6); 71.4% (CI 67.3-75.2); 89.8% (CI 86.692.3); and 95.7% (CI 93.4-97.3), respectively, in patients with NMIBC other than T1 HG/G3 or T0 tumors. Residual T1 HG/G3 was independently associated with RFS, PFS, OS, and CSS in multivariable analyses. Conclusions: Residual T1 HG/G3 tumor at re-TUR confers worse prognosis in patients with primary T1 HG/G3 treated with maintenance BCG. Patients with residual T1 HG/G3 for primary T1 HG/G3 are very likely to fail BCG therapy alone. (C) 2018 S. Karger AG, Basel
Original languageEnglish
Pages (from-to)7-15
Number of pages9
JournalUrologia Internationalis
Volume101
Publication statusPublished - 2018

All Science Journal Classification (ASJC) codes

  • Urology

Fingerprint

Dive into the research topics of 'High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study'. Together they form a unique fingerprint.

Cite this